Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]

Immunotherapy in lung cancer

Dr Luis Raez - Memorial Healthcare System, Hollywood, Florida, USA

Immunotherapy in lung cancer ( Dr Luis Raez - Memorial Healthcare System, Hollywood, Florida, USA )

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 12- July 18, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle...

Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy

Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )

ASCO 2021: Lung roundup

Dr Luis Raez - Memorial Healthcare System, FL, USA

ASCO 2021: Lung roundup ( Dr Luis Raez - Memorial Healthcare System, FL, USA )

Isatuximab, carfilzomib, lenalidomide and dexamethasone for high risk MM

Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg...

Isatuximab, carfilzomib, lenalidomide and dexamethasone for high risk MM ( Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care...

Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA

JAVELIN Bladder 100: Avelumab first-line maintenance plus best supportive care (BSC) versus BSC alone for advanced UC ( Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA )

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin...

Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA

PrE0807: Neoadjuvant nivolumab without or with lirilumab in cisplatin-ineligible patients with muscle-invasive bladder cancer ( Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA )

Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R B-cell non...

Dr Nilanjan Ghosh - Atrium Health Levine Cancer Institute, Charlotte, USA

Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R B-cell non-Hodgkin’s lymphoma ( Dr Nilanjan Ghosh - Atrium Health Levine Cancer Institute, Charlotte, USA )

Efficacy and safety of tisagenlecleucel in adult patients with relapsed...

Dr Stephen Schuster - Perelman Center for Advanced Medicine, Philadelphia, USA

$Efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma ( Dr Stephen Schuster - Perelman Center for Advanced Medicine, Philadelphia, USA )$

Breast cancer roundup from ASCO 2021

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Breast cancer roundup from ASCO 2021 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Real world evidence on the use of antibody drug conjugates in peripheral T-cell...

Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut...

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )

Pembrolizumab improves on chemo in MSI-H/dMMR mCRC

Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris...

Pembrolizumab improves on chemo in MSI-H/dMMR mCRC ( Prof Thierry André - Sorbonne University and Saint-Antoine Hospital, Paris, France )

More from ecancer